Lonza Group Ltd

LONN: XSWX (CHE)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|^xLOCK|&cFkLOCK|d%Xk^$v

Lonza Earnings: Solid Demand for ADC and Biologics Supports Multiyear Growth

Lonza reported sales of CHF 3.4 billion in the first half of 2026, up 16% at constant exchange rates from the prior-year period. Management maintained its 2026 outlook of 11%-12% sales growth, but it raised the core EBITDA margin outlook to 33%-34%. Shares fell nearly 5% on July 22.

Sponsor Center